Methods for reducing the risk of cardiovascular events in a subject with a composition containing icosapent ethyl
MA50490B1Active Publication Date: 2026-08-31AMARIN PHARMACEUTICALS IRELAND LIMITED(IE)
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- MA50490
- Authority / Receiving Office
- MA · MA
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2019-04-22
- Filing Date
- 2019-04-22
- Publication Date
- 2026-08-31
- Estimated Expiration
- 2039-04-22
Abstract
In various embodiments, the present invention relates to methods of reducing the risk of cardiovascular events in a subject under statin treatment by administering a pharmaceutical composition comprising approximately 1 g to approximately 4 g of ethyl ester of eicosapentaenoic acid or a derivative thereof.
Need to check novelty before this filing date? Find Prior Art